उत्पाद विवरण
Kadcyla 100 mg Injection is a targeted treatment designed specifically for certain types of breast cancer characterized by an overproduction of the HER2 protein, which often leads to aggressive tumor growth. This innovative therapy combines a monoclonal antibody with a microtubule inhibitor, allowing it to effectively deliver powerful cancer-fighting agents directly to the affected cells. By binding to the HER2 protein on cancer cells, Kadcyla disrupts their ability to grow and divide, ultimately leading to cell death and tumor reduction. It's important to be aware that Kadcyla may have side effects, including low blood cell counts and liver issues, necessitating regular monitoring during treatment. Patients should inform their healthcare provider of any existing medical conditions or medications to avoid potential interactions. This therapy offers hope to those battling HER2-positive breast cancer, providing a more personalized approach to treatment. As with any medication, discussing the benefits and risks with a healthcare professional is essential for optimal outcomes. With Kadcyla, patients can take a proactive step in their cancer treatment journey.
Precision Oncology TreatmentKadcyla 100 mg Injection represents advanced oncology care, specifically designed for targeted cancer therapy. Manufactured by Roche and of Swiss origin, it is suited for patients undergoing specialized treatment regimens under strict medical guidance. The intravenous administration ensures effective delivery directly into the bloodstream for optimal therapeutic benefit.
Trusted Distribution Across IndiaAvailable in 2-piece packs and exclusively handled by distributors, exporters, suppliers, and wholesalers throughout India, Kadcyla is supported by a robust supply chain. Its glass vial packaging and liquid physical form maintain product integrity during storage and transportation, ensuring reliability for healthcare providers.
FAQ's of Kadcyla 100 mg Injection:
Q: How is Kadcyla 100 mg Injection administered?
A: Kadcyla 100 mg Injection is given intravenously, meaning it is injected directly into a vein by a qualified healthcare professional in a clinical or hospital setting for safety and effectiveness.
Q: What is the main use of Kadcyla 100 mg Injection?
A: This medication is primarily used as an advanced cancer therapy, especially for specific types of breast cancer, as determined and prescribed by a doctor. Its targeted action helps inhibit cancer cell growth.
Q: When should Kadcyla 100 mg Injection be used?
A: Your doctor will determine the appropriate timing and frequency based on your treatment protocol. It is typically scheduled every three weeks, but your medical team will tailor the regimen according to your individual needs.
Q: Where can Kadcyla 100 mg Injection be obtained?
A: Kadcyla is available through authorized distributors, exporters, suppliers, traders, and wholesalers in India. It is issued by prescription only and must be administered in a healthcare facility.
Q: What is the process for preparing Kadcyla 100 mg Injection for use?
A: A trained pharmacist or nurse reconstitutes the liquid in the 100 mg glass vial according to strict guidelines before intravenous infusion, ensuring proper dosage and sterility.
Q: Who should administer Kadcyla 100 mg Injection?
A: This medication must always be administered by a doctor or a qualified healthcare professional to ensure correct dosing and to monitor for any potential side effects.
Q: What are the key benefits of using Kadcyla 100 mg Injection?
A: Kadcyla provides targeted cancer therapy, minimizing harm to normal cells and often resulting in better outcomes and potentially fewer side effects compared to traditional chemotherapy in eligible patients.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese